CIK 0001833769 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,545
- in 2 filings
Net −$12,545. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-31 | Siddiqui Khan CMO and Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +1,796 | 1,796 | ||
| 2022-10-31 | Siddiqui Khan CMO and Chief Strategy Officer | Returned to the company · Stock Option (right to buy) | −110,000 | 0 | ||
| 2022-10-31 | Siddiqui Khan CMO and Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-10-31 | Siddiqui Khan CMO and Chief Strategy Officer | Returned to the company · Stock Option (right to buy) | −74,000 | 0 | ||
| 2022-10-31 | Siddiqui Khan CMO and Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +74,000 | 74,000 | ||
| 2022-10-31 | Gupta Alok Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −200,000 | 0 | ||
| 2022-10-31 | Gupta Alok Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-10-31 | Gupta Alok Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −54,333 | 0 | ||
| 2022-10-31 | Gupta Alok Chief Financial Officer | Grant or award · Stock Option (right to buy) | +54,333 | 54,333 | ||
| 2022-10-31 | Paykel Neela Gen Counsel & Corp Secretary | Returned to the company · Stock Option (right to buy) | −71,750 | 0 | ||
| 2022-10-31 | Paykel Neela Gen Counsel & Corp Secretary | Grant or award · Stock Option (right to buy) | +71,750 | 71,750 | ||
| 2022-10-31 | Paykel Neela Gen Counsel & Corp Secretary | Returned to the company · Stock Option (right to buy) | −85,000 | 0 | ||
| 2022-10-31 | Paykel Neela Gen Counsel & Corp Secretary | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2022-10-31 | Paykel Neela Gen Counsel & Corp Secretary | Returned to the company · Stock Option (right to buy) | −98,250 | 0 | ||
| 2022-10-31 | Paykel Neela Gen Counsel & Corp Secretary | Grant or award · Stock Option (right to buy) | +98,250 | 98,250 | ||
| 2022-10-31 | Huennekens R Scott Director | Returned to the company · Stock Option (right to buy) | −237,437 | 0 | ||
| 2022-10-31 | Huennekens R Scott Director | Grant or award · Stock Option (right to buy) | +237,437 | 237,437 | ||
| 2022-10-31 | Huennekens R Scott Director | Returned to the company · Stock Option (right to buy) | −712,312 | 0 | ||
| 2022-10-31 | Huennekens R Scott Director | Grant or award · Stock Option (right to buy) | +712,312 | 712,312 | ||
| 2022-10-31 | Huennekens R Scott Director | Returned to the company · Stock Option (right to buy) | −237,437 | 0 |
Page 5 of 8 · 149 trades